LCA168 FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain malignancy known for its rapid growth and unresponsiveness to typical treatments. Investigations are constantly underway to identify new management strategies, and recently, a novel biomarker named LCA168 has emerged as a potential avenue for glioblastoma treatment. LCA168 is a protein that is highly expressed in